“Synthesis of New inhibitors of the FibrillogenesisAß42: Alzheimer’s Disease”, Med. Technol. J., vol. 2, no. 4, pp. 315–315, Jan. 2019, doi: 10.26415/2572-004X-vol2iss4p315-315.